Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-085918
Filing Date
2021-03-18
Accepted
2021-03-18 16:54:02
Documents
7
Period of Report
2021-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d76711ddef14a.htm DEF 14A 1283629
2 GRAPHIC g76711g08s30.jpg GRAPHIC 160589
3 GRAPHIC g76711g20h20.jpg GRAPHIC 96319
4 GRAPHIC g76711g21g21.jpg GRAPHIC 138507
5 GRAPHIC g76711g22h30.jpg GRAPHIC 28958
6 GRAPHIC g76711g46s63.jpg GRAPHIC 209944
7 GRAPHIC g76711g81n51.jpg GRAPHIC 47766
  Complete submission text file 0001193125-21-085918.txt   2224668
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36569 | Film No.: 21755012
SIC: 2835 In Vitro & In Vivo Diagnostic Substances